Research Focus

SKI Medicine; Research Fellow 009050

Recent additions – View all

1. Synergistic effect of HAD-B1 and osimertinib against gefitinib resistant HCC827 non-small cell lung cancer cells

   Journal Article

   Ko, E. J.; Kwag, E. B.; Park, J. H.; Cho, S. H.; Park, S. J.; Jung, M. K.; Kang, I. C.; Yoo, H. S.
   Integrative Cancer Therapies (2025)

   Fulltext@MSK | Save
2. Effectiveness and safety of combined treatment with herbal medicines and palliative chemotherapy for advanced gastric cancer: A systematic review, and meta-analysis

   Review

   Kim, D. H.; Kim, S. D.; Jun, H. J.; Kwag, E. B.; Shin, S. W.; Yoo, H. S.; Park, S. J.
   Integrative Medicine Research (2025)

   Fulltext@MSK | Save
3. A randomized, multi-center, open label study to compare the safety and efficacy between afatinib monotherapy and combination therapy with HAD-B1 for the locally advanced or metastatic NSCLC patients with EGFR mutations

   Journal Article

   Kwag, E.; Kim, S. D.; Shin, S. H.; Oak, C.; Park, S. J.; Choi, J. Y.; Hoon Yoon, S.; Kang, I. C.; Jeong, M. K.; Woo Lee, H.; more...
   Integrative Cancer Therapies (2024)

   Fulltext@MSK | Save